Thyme Care
PrivateLast Round
Series E
Sep 2, 2026
Est. Valuation
$2B
Total Funding Raised
$399M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Thyme Care is a healthcare technology company that provides an oncology care platform to support cancer patients throughout their treatment journey with physician-guided nursing and resource specialists, enhancing access to quality care and actionable insights for early intervention.
Sector
Healthcare & Life Sciences
Verticals
Healthcare Analytics, Patient Engagement, Vertical SaaS, Medical AI
Business Model
B2B2C
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Thyme Care Comparables
Compare Thyme Care with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Atlas Oncology Partners | 78% | |
| Evolent Health | 77% | |
| OncoHealth | 76% |
Thyme Care Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series E | Sep 2, 2026 | ||||
| Series D | Sep 25, 2025 | ||||
| Debt | Jul 16, 2024 | ||||
| Series C | Jul 16, 2024 | ||||
| Series B | Aug 22, 2023 | ||||
Series A | Oct 5, 2021 |
Key People
Founding team and executive leadership
Thyme Care Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Series C, Series E, Series B, Series A, Series D |
| Town Hall Ventures | Series C, Series E, Series B, Series D |
| AlleyCorp | Series C, Series E, Series B, Series A, Series D |
| Frist Cressey Ventures | Series C, Series E, Series B, Series A, Series D |
| Texas Oncology | Series D |
| Foresite Capital | Series C, Series E, Series B, Series D |
| Morgan Health | Series D, Series E |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 2, 2026
$125M round led by Morgan Health
- Jul 25, 2026
Monthly visitors increased 67% MoM.
Recent news
Latest coverage and updates
- partners_withOct 15, 2026
Thyme Care, Inc. partners with Texas Oncology under a value-based care agreement to use weight-based pembrolizumab dosing, reducing costs for their shared Medicare Advantage population in Tennessee on Oct 15th '26.
- promotesSep 4, 2026
In July '26, Thyme Care, Inc. announces plans to promote Dr. Brad Diephuis, previously its president and chief operating officer, to CEO, succeeding cofounder Robin Shah.
- recognized_asSep 2, 2026
Thyme Care, Inc. ranks No. 18 on CNBC’s 2026 Disruptor 50 list.
- receives_financingSep 2, 2026
Thyme Care, Inc. closed a $125M Series E led by Morgan Health, with participation from CVS Health Ventures, Humana, and other investors, on Sep 2nd '26 in Tennessee to accelerate growth and broaden its oncology-care impact.
Thyme Care Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Thyme Care's valuation, stock price, and market status.
Is Thyme Care a public or private company?
Thyme Care is a private company.
What is the current stock price of Thyme Care?
Thyme Care is a private company, so its shares have no public market price. Caplight tracks Thyme Care's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Thyme Care worth (valuation)?
Thyme Care's valuation is estimated at $2.0B based on funding round data.
Can I buy Thyme Care stock?
Thyme Care shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Thyme Care's last funding round?
Thyme Care's most recent funding round was Series E on September 2, 2026.
Who are the main investors in Thyme Care?
Key investors in Thyme Care include Andreessen Horowitz, Town Hall Ventures, AlleyCorp, Frist Cressey Ventures, Foresite Capital.
Will Thyme Care IPO soon?
No public IPO plans have been announced for Thyme Care.
How can I track Thyme Care secondary market activity?
Caplight tracks bids, offers, and trades in Thyme Care's shares on secondary markets.